Display options
Share it on

Am J Surg Pathol. 2009 Sep;33(9):1378-85. doi: 10.1097/PAS.0b013e3181aa30a5.

Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.

The American journal of surgical pathology

Klaus J Busam, Achim A Jungbluth, Natasha Rekthman, Daniel Coit, Melissa Pulitzer, Jason Bini, Reety Arora, Nicole C Hanson, Jodie A Tassello, Denise Frosina, Patrick Moore, Yuan Chang

Affiliations

  1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. [email protected]

PMID: 19609205 PMCID: PMC2932664 DOI: 10.1097/PAS.0b013e3181aa30a5

Abstract

Merkel cell carcinoma (MCC) is the eponym for primary cutaneous neuroendocrine carcinoma. Recently, a new polyoma virus has been identified that is clonally integrated in the genome of the majority of MCCs, with truncating mutations in the viral large T antigen gene. We examined the presence of Merkel cell polyomavirus (MCV) in a set of 17 frozen tumor samples by quantitative polymerase chain reaction; 15 of them (88%) were positive. Sections from corresponding archival material were analyzed by immunohistochemistry (IHC) with the novel monoclonal antibody CM2B4, generated against a predicted antigenic epitope on the MCV T antigen, and tested for the expression of cytokeratin 20 (CK20). Sufficient archival material for IHC was available in only 15 of the 17 cases whose frozen tissue samples had been studied by polymerase chain reaction. Of the 15 tumors analyzed immunohistochemically, 10 (67%) showed positive labeling with CM2B4, 14 (93%) expressed CK20. A tissue microarray of 36 MCCs, 7 combined squamous and neuroendocrine carcinomas of the skin, and 26 pulmonary neuroendocrine carcinomas were also examined by IHC. Of the 36 MCCs assembled on a microarray, 32 (89%) tumors expressed CK20, and 27 (75%) were immunoreactive with CM2B4. The skin tumors with a combined squamous and neuroendocrine phenotype and all pulmonary neuroendocrine carcinomas failed to react with CM2B4. Our study shows that CM2B4 is a useful reagent for the diagnosis of MCC. It labels the majority of MCCs, but fails to react with pulmonary neuroendocrine carcinomas. We also found that neuroendocrine carcinomas of the skin arising in association with a squamous cell carcinoma seem to be independent of MCV.

References

  1. Cancer. 1986 Sep 1;58(5):1040-6 - PubMed
  2. J Am Acad Dermatol. 2003 Nov;49(5):832-41 - PubMed
  3. Ann Diagn Pathol. 2006 Dec;10(6):376-85 - PubMed
  4. Anticancer Drugs. 2003 Mar;14(3):251-3 - PubMed
  5. Am J Dermatopathol. 2006 Apr;28(2):99-104 - PubMed
  6. Transplant Proc. 2002 Aug;34(5):1780-1 - PubMed
  7. Transplantation. 1999 Dec 15;68(11):1717-21 - PubMed
  8. Hum Pathol. 2001 Jul;32(7):680-9 - PubMed
  9. Int J Cancer. 2009 Sep 15;125(6):1243-9 - PubMed
  10. Am J Surg Pathol. 1985 Feb;9(2):95-108 - PubMed
  11. Am J Surg Pathol. 1997 Feb;21(2):226-34 - PubMed
  12. Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7 - PubMed
  13. Am J Dermatopathol. 1982 Dec;4(6):501-5 - PubMed
  14. Cancer. 2008 Nov 1;113(9):2549-58 - PubMed
  15. Cancer. 2007 Jul 1;110(1):1-12 - PubMed
  16. Science. 2008 Feb 22;319(5866):1096-100 - PubMed
  17. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):153-8 - PubMed
  18. Lancet. 2002 Feb 9;359(9305):497-8 - PubMed
  19. Histopathology. 1983 Mar;7(2):229-49 - PubMed
  20. Arch Pathol Lab Med. 2001 Feb;125(2):228-31 - PubMed
  21. J Surg Oncol. 2005 Jan 1;89(1):1-4 - PubMed
  22. J Invest Dermatol. 2009 Jan;129(1):248-50 - PubMed
  23. J Invest Dermatol. 2007 Sep;127(9):2100-3 - PubMed
  24. Pathology. 1986 Oct;18(4):393-9 - PubMed
  25. J Invest Dermatol. 2009 Jun;129(6):1547-55 - PubMed
  26. Cancer. 1978 Nov;42(5):2311-21 - PubMed
  27. J Invest Dermatol. 2009 Jan;129(1):246-8 - PubMed
  28. J Am Acad Dermatol. 1998 Nov;39(5 Pt 2):882-7 - PubMed
  29. Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):310-5 - PubMed
  30. J Dermatol. 2003 Mar;30(3):241-4 - PubMed
  31. Arch Dermatol. 1972 Jan;105(1):107-10 - PubMed
  32. Mod Pathol. 2008 Nov;21(11):1357-62 - PubMed
  33. J Am Acad Dermatol. 2008 Mar;58(3):375-81 - PubMed
  34. Am J Dermatopathol. 1982 Dec;4(6):537-48 - PubMed
  35. J Clin Oncol. 2005 Apr 1;23(10):2300-9 - PubMed
  36. Cancer Res. 2008 Jul 1;68(13):5009-13 - PubMed

Substances

MeSH terms

Publication Types

Grant support